3billion (394800.KQ) has a MoatMap StockRank of 12/100 based on Quality (35/100), Value (36/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL.
3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment.
| Price | $4.85 |
| Market Cap | $154M |
| P/E (Forward) | 39.67 |
| Price/Book | 9.91 |
| Return on Equity | -20.9% |
| Return on Invested Capital | -19.8% |
| Debt/Equity | 14.24 |
| Gross Margin | -50.3% |
| Operating Margin | -27.3% |
| Revenue Growth | 98.3% |
| Free Cash Flow | $-808.92 |
3billion operates in the Biotechnology industry, part of the Healthcare sector (South Korea).